Related Experiment Video
Updated: Jul 26, 2025

07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
41.3K
Acrometastasis in Breast Carcinoma
Caroline Galliano1, R Taylor Bragg2, Paresh Rangani2
1Louisiana State University School of Medicine, New Orleans, LA.
Ochsner Journal
|June 16, 2023
Summary
Metastatic breast cancer rarely spreads to the appendicular skeleton, such as the thumb. This rare acrometastasis presentation often indicates widespread, late-stage disease.
Area of Science:
- Oncology
- Skeletal Metastasis
Background:
- Bone metastasis is common in breast cancer patients.
- Metastasis to the appendicular skeleton, particularly distal limbs (acrometastasis), is rare.
- Acrometastasis in breast cancer warrants investigation for diffuse metastatic disease.
Observation:
- A patient with recurrent triple-negative metastatic breast cancer presented with thumb pain and swelling.
- Radiographs revealed soft tissue swelling and erosive bone changes in the first distal phalanx.
- Palliative radiation provided temporary symptom relief.
Findings:
- The thumb lesion was confirmed as metastatic breast adenocarcinoma.
- The patient ultimately succumbed to widespread metastatic disease.
- Autopsy confirmed the thumb lesion as metastatic breast cancer.
Implications:
- Metastatic breast carcinoma to the distal appendicular skeleton is a rare finding.
- This presentation can signify late-stage, disseminated breast cancer.
- Early recognition of acrometastasis is crucial for patient management.
Related Concept Videos
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

